Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Modifications of carbon black nanoparticle surfaces modulate type II pneumocyte homoeostasis.

Schreiber N, Ströbele M, Hochscheid R, Kotte E, Weber P, Bockhorn H, Müller B.

J Toxicol Environ Health A. 2016;79(4):153-64. doi: 10.1080/15287394.2015.1124819. Epub 2016 Feb 25.

PMID:
26914170
2.

Nitration of protein without allergenic potential triggers modulation of antioxidant response in type II pneumocytes.

Hochscheid R, Schreiber N, Kotte E, Weber P, Cassel W, Yang H, Zhang Y, Pöschl U, Müller B.

J Toxicol Environ Health A. 2014;77(12):679-95. doi: 10.1080/15287394.2014.888023.

PMID:
24786675
3.

Lung alterations following single or multiple low-dose carbon black nanoparticle aspirations in mice.

Schreiber N, Ströbele M, Kopf J, Hochscheid R, Kotte E, Weber P, Hansen T, Bockhorn H, Müller B.

J Toxicol Environ Health A. 2013;76(24):1317-32. doi: 10.1080/15287394.2013.853634.

PMID:
24283474
4.

NO2-induced acute and chronic lung injury cause imbalance of glutathione metabolism in type II pneumocytes.

Hochscheid R, Schuchmann U, Kotte E, Kranz S, Heinrichs S, Müller B.

Med Sci Monit. 2005 Aug;11(8):BR273-9. Epub 2005 Jul 25.

PMID:
16049373
5.
6.
7.

Effect of N-acetylcysteine treatment on NO2-impaired type II pneumocyte surfactant metabolism.

Müller B, Oske M, Hochscheid R, Seifart C, Barth PJ, Garn H, von Wichert P.

Eur J Clin Invest. 2001 Feb;31(2):179-88.

PMID:
11168458
8.

alpha-tocopherol improves impaired physiology of rat type II pneumocytes isolated from experimentally injured lungs.

Müller B, Hochscheid R, Seifart C, Barth PJ.

Eur J Clin Invest. 2000 Nov;30(11):1018-26.

PMID:
11114965

Supplemental Content

Loading ...
Support Center